TCL Archive In Brief: NCI’s John Czajkowski Takes Executive Dean Position At Harvard Medical School February 21, 2014
TCL Archive NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent. February 23, 2001
TCL Archive Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL December 27, 2013
TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
